These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 30405002)

  • 1. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
    Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
    Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Veeraraghavan S; Latsi PI; Wells AU; Pantelidis P; Nicholson AG; Colby TV; Haslam PL; Renzoni EA; du Bois RM
    Eur Respir J; 2003 Aug; 22(2):239-44. PubMed ID: 12952254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
    Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
    J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and NKT-like cells in granulomatous and fibrotic lung diseases.
    Bergantini L; Cameli P; d'Alessandro M; Vagaggini C; Refini RM; Landi C; Pieroni MG; Spalletti M; Sestini P; Bargagli E
    Clin Exp Med; 2019 Nov; 19(4):487-494. PubMed ID: 31485847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases.
    Bergantini L; d'Alessandro M; Cameli P; Otranto A; Finco T; Curatola G; Sestini P; Bargagli E
    Clin Immunol; 2021 Sep; 230():108827. PubMed ID: 34428741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
    Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
    Front Immunol; 2021; 12():645548. PubMed ID: 34867934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias.
    Ryu YJ; Chung MP; Han J; Kim TS; Lee KS; Chun EM; Kyung SY; Jeong SH; Colby TV; Kim H; Kwon OJ
    Respir Med; 2007 Mar; 101(3):655-60. PubMed ID: 16919929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype.
    Inoue Y; Kaner RJ; Guiot J; Maher TM; Tomassetti S; Moiseev S; Kuwana M; Brown KK
    Chest; 2020 Aug; 158(2):646-659. PubMed ID: 32268131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.